Jubilant Pharmova Limited (JUBLPHARMA) Share Price & AI Investment Analysis

Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of pulmonary embolism, cancer, coronary artery disease, and other diseases. Its Allergy Immunotherapy segment provides. Track Jubilant Pharmova Limited's live NSE:JUBLPHARMA share price ₹1,065.40 (+5.27%), market cap ₹₹169B, P/E 48.1. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for JUBLPHARMA — real-time NSE India stock intelligence.